药物不良反应数据集

该数据集可助力识别未知药物风险，提升用药安全，支撑监管机构制定风险管控措施（如修改说明书或撤市），优化药品全周期管理，为药企提供上市后监测依据，指导研发改进与风险预警，赋能医疗专业人员调整临床用药策略，降低患者治疗风险，推动药物流行病学研究和AI预测模型开发，实现主动药物警戒改数。

This dataset can assist in identifying unknown drug risks, enhancing medication safety, supporting regulatory agencies in formulating risk management measures such as revising drug package inserts or withdrawing drugs from the market, optimizing the full-cycle management of pharmaceuticals, providing post-marketing surveillance evidence for pharmaceutical enterprises, guiding R&D improvements and risk early warning, empowering medical professionals to adjust their clinical medication strategies, reducing treatment risks for patients, promoting pharmacoepidemiological research and the development of AI prediction models, and realizing the digitization of active pharmacovigilance.